Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy

High-grade neuroepithelial tumor of the central nervous system with BCOR alteration (HGNET-BCOR) is a rare, highly malignant tumor. At the time of this publication, no standard protocol exists to treat this tumor entity. In this work, we tested the responsiveness of the primary culture PhKh1 derived...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Paret, Claudia, Russo, Alexandra, Otto, Henrike, Mayer, Arnulf, Zahnreich, Sebastian, Wagner, Wolfgang, Samuel, David, Scharnhorst, David, Solomon, David A., Dhall, Girish, Wong, Kenneth, Bender, Hannah, Alt, Francesca, Wingerter, Arthur, Neu, Marie A., Beck, Olaf, Prawitt, Dirk, Eder, Stefan, Henninger, Nicole, El Malki, Khalifa, Lehmann, Nadine, Backes, Nora, Roth, Lea, Seidmann, Larissa, Sommer, Clemens, Brockmann, Marc A., Staatz, Gundula, Schmidberger, Heinz, Faber, Jörg
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5768397/
https://ncbi.nlm.nih.gov/pubmed/29371980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23174
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi